The Vatican will host a congress, Nov 9-11, to promote the use of adult stem cells as a safe, effective and ethical means to fight degenerative diseases.

Vatican, biotech firm host congress to promote adult stem-cell therapy

By  Carol Glatz, Catholic News Service
  • June 17, 2011

VATICAN CITY - The Vatican will host an international congress to promote the use of adult stem cells as a safe, effective and ethical means to fight degenerative diseases.

The congress, to be held Nov. 9-11, will also feature speakers who support embryonic stem-cell research, to give proponents an opportunity to "explain the reasoning behind their position," said Father Tomasz Trafny, an official with the Pontifical Council for Culture. The church is opposed to the use of embryonic stem cells since it involves the destruction of the human embryo.

The congress, organized by the Vatican's councils for Culture and Health Care Ministry as well as the Pontifical Academy for Life, is being held in conjunction with the international biopharmaceutical company, NeoStem.

The congress will be the culture council and the biotech firm's first major collaborative project since they forged an agreement in 2010 to work together to educate people about the benefits of adult stem-cell research. The collaboration is between NeoStem's Stem for Life  Foundation and the culture council's foundation -- called STOQ International, for Science, Theology and the Ontological Quest.

The interdisciplinary congress, "Adult Stem Cells: Science and the Future of Man and Culture," will feature expert speakers from the fields of medicine, health and ethics.

Father Trafny said at a Vatican news conference June 16 that proponents of embryonic stem-cell research will have an "opportunity to defend their position" and give their reasons for pursuing a field that is not only unethical, but has not yet produced any concrete benefits.

He said some governments may be investing money in embryonic rather than adult stem-cell research because most government officials making these decisions are not medical experts and are influenced by others to choose which path to take.

That is why it is important to increase people's understanding about the concrete beneficial results coming out of adult stem-cell therapies, he added.

That is also why the target audience for the congress will be people "who do not have a real scientific background" such as policymakers, lawyers, government representatives, bishops and journalists.

Please support The Catholic Register

Unlike many media companies, The Catholic Register has never charged readers for access to the news and information on our website. We want to keep our award-winning journalism as widely available as possible. But we need your help.

For more than 125 years, The Register has been a trusted source of faith-based journalism. By making even a small donation you help ensure our future as an important voice in the Catholic Church. If you support the mission of Catholic journalism, please donate today. Thank you.

DONATE